Advisor Group Holdings, Inc. Iveric Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$26.24 - $39.63 $892 - $1,347	34 Added 6.69%	542 $21,000
Q1 2023 May 12, 2023	BUY	$18.67 - $24.56 $3,043 - $4,003	163 Added 47.25%	508 $12,000
Q4 2022 Feb 10, 2023	SELL	$17.24 - $23.95 $1,534 - $2,131	-89 Reduced 20.51%	345 $7,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $3,948 - $7,807	420 Added 3000.0%	434 $8,000
Q2 2022 Aug 10, 2022	BUY	$9.12 - $18.9 $127 - $264	14 New	14 $0
Q1 2021 May 13, 2021	SELL	$5.08 - $6.89 $685 - $930	-135 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.06 - $6.6 $504 - $1,089	-165 Reduced 55.0%	135 $1,000
Q1 2020 May 18, 2020	BUY	$2.83 - $8.44 $849 - $2,532	300 New	300 $1,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.